Alan Nicholas

发表论文 73 篇 · 总被引 3032 次 · h-index 17

代表论文

• Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial (2022 · Nature Medicine · 被引 248)
• Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer (2022 · Journal of Thoracic and Cardiovascular Surgery · 被引 43)
• Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab (2024 · Journal of Clinical Oncology · 被引 37)
• Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150 (2024 · Liver Cancer · 被引 37)
• Artificial Intelligence–Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study (2023 · Journal of Thoracic Oncology · 被引 34)
• Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data (2023 · npj Breast Cancer · 被引 19)